BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12930494)

  • 1. Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion.
    Tse HF; Lau CP
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1809-14. PubMed ID: 12930494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.
    Tse HF; Lau CP; Ayers GM
    Heart; 1999 Sep; 82(3):319-24. PubMed ID: 10455082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
    Biffi M; Boriani G; Bartolotti M; Bacchi Reggiani L; Zannoli R; Branzi A
    Heart; 2002 May; 87(5):443-8. PubMed ID: 11997417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early reinitiation of atrial fibrillation following external electrical cardioversion in amiodarone-treated patients.
    Reithmann C; Dorwarth U; Gerth A; Remp T; Steinbeck G; Hoffmann E
    J Interv Card Electrophysiol; 2001 Sep; 5(3):285-92. PubMed ID: 11500583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and management of early recurrent atrial fibrillation (ERAF) after transthoracic electrical cardioversion.
    Siaplaouras S; Jung J; Buob A; Heisel A
    Europace; 2004 Jan; 6(1):15-20. PubMed ID: 14697721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of electrical shock waveform and paddle positions on efficacy of direct current cardioversion for atrial fibrillation].
    Stanaitiene G; Babarskiene RM
    Medicina (Kaunas); 2008; 44(9):665-72. PubMed ID: 18971603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.
    Nergärdh A; Nordlander R; Frick M
    Clin Cardiol; 2006 Feb; 29(2):56-60. PubMed ID: 16506639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.
    Kumar S; Sutherland F; Morton JB; Lee G; Morgan J; Wong J; Eccleston DE; Voukelatos J; Garg ML; Sparks PB
    Heart Rhythm; 2012 Apr; 9(4):483-91. PubMed ID: 22120130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
    Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
    Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of left ventricular diastolic dysfunction assessed by pulsed tissue Doppler imaging as a predictor of atrial fibrillation recurrence after successful electrical cardioversion.
    Caputo M; Urselli R; Capati E; Navarri R; Sinesi L; Furiozzi F; Ballo P; Palazzuoli A; Favilli R; Mondillo S
    Am J Cardiol; 2011 Sep; 108(5):698-704. PubMed ID: 21723530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
    Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.
    Duytschaever M; Haerynck F; Tavernier R; Jordaens L
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):284-7. PubMed ID: 9474689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes.
    Lai LP; Lin JL; Lien WP; Tseng YZ; Huang SK
    J Am Coll Cardiol; 2000 May; 35(6):1434-41. PubMed ID: 10807444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation.
    Efremidis M; Alexanian IP; Oikonomou D; Manolatos D; Letsas KP; Pappas LK; Gavrielatos G; Vadiaka M; Mihas CC; Filippatos GS; Sideris A; Kardaras F
    Can J Cardiol; 2009 Apr; 25(4):e119-24. PubMed ID: 19340356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
    Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.